Loading...
Loading...
Morgan Stanley reduced its rating on Cerner Corporation
CERN from Overweight to Equal-weight and removes its prior price target of $82.
Morgan Stanley commented, "Challenging y/y comparisons, associated with approaching deadlines for attesting to Stage 1 Meaningful Use, should lead to slower bookings growth by 2013. With shares trading at a premium to historical valuation and to the broader software group, we see limited upside potential in the near-term."
Cerner Corporation closed at $73.75 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in